Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Bravo! Leede Jones Gable
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by MustangSalleyon Mar 31, 2021 1:28pm
127 Views
Post# 32915200

RE:Bravo! Leede Jones Gable

RE:Bravo! Leede Jones Gable
Charly50 wrote:
Leede Jones Gable Inc. on the seller side since day ...
What's going on there??


 

What do you expect when you do a poor deal like this ? Canacorrd is probably done shorting , so Leed comes in now to do their bit ?   

Where is all the US institutional buying ? Loe is an analyst but remember he recommended it at $2.50 when the stock was trading at $2.80 ?  God knows how you do not have a conflict of interest submitting an analyst report while negotiating a price for a financing ? Nothing to look at here folks .
 

Charly call the lapdog Dominic and ask what the difference between a bought deal done by quality institutions is and one done by Canacorrd/Leed Jones is ? 


Enough is enough !

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities